Business

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of HY-1016 Sustained-release Injection Obtaining Notice of Approval for Drug Clinical Trial

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of HY-1016 Sustained-release Injection Obtaining Notice of Approval for Drug Clinical Trial

articleSichuan Huiyu Pharmaceutical Co. Ltd. Class AJune 30, 20264/news/sichuan-huiyu-pharmaceutical-co-ltdannouncement-on-voluntary-disclosure-of-hy-1016-sustained-release-injection-obtaining-notice-of-approval-for-drug-clinical-trial
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of HY-1016 Sustained-release Injection Obtaining Notice of Approval for Drug Clinical Trial

About this update from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of HY-1016 Sustained-release Injection Obtaining Notice of Approval for Drug Clinical TrialThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Sichuan Huiyu Pharmaceutical Co. Ltd. Class A